Histopathological examination of tissue samples acquired by performing a US-guided core-needle biopsy of the tumor showed matrix-producing carcinoma that was estrogen receptor (ER)-negative, progesterone receptor (PgR)-negative, and human epidermal growth factor receptor 2 (HER2)-negative immunohistochemically. Here, ERBB2 is linked to carcinoma.